Summit Therapeutics Inc. (SMMT): Shares Outstanding

Annual figures by period end, from SEC filings.

775.37M
As of 2025-12-31
793.12M
As of 2026-06-30
+54.3%
3-year compound annual growth
+56.5%
5-year compound annual growth
2019-12-31: 67.18M2020-12-31: 82.58M2021-12-31: 98.04M2022-12-31: 211.09M2023-12-31: 701.66M2024-12-31: 737.63M2025-12-31: 775.37M775.37M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31775.37M+5.1%2026-02-23, Balance as of period end
2024-12-31737.63M+5.1%2026-02-23, Balance as of period end
2023-12-31701.66M+232.4%2025-02-24, Balance as of period end
2022-12-31211.09M+115.3%2024-02-20, Balance as of period end
2021-12-3198.04M+18.7%2023-03-09, Balance as of period end
2020-12-3182.58M+22.9%2022-12-21, Balance as of period end
2019-12-3167.18Mn/a2021-03-31, Balance as of period end